Fig. 3
After 3 months, 70% and 65% of patients exhibited a reduction in 24-h mean systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively (A, B). Among them, 50% experienced a decrease in SBP greater than 10 mmHg, accompanied by a mean medication burden (MB) reduction of −0.7. Additionally, 27.5% showed a DBP reduction greater than 10 mmHg, with an associated MB decrease of −0.5. A further 12.5% of patients had reductions of 5–10 mmHg in both SBP and DBP, with corresponding MB decreases of −0.2 and −0.8, respectively. At six months post-procedure, 67% of patients demonstrated a reduction in 24-h mean SBP, and 55% showed a reduction in DBP (C, D). Specifically, 34% experienced an SBP decrease of more than 10 mmHg, along with a reduction in MB of −2.6. Additionally, 10% of patients had a DBP decrease greater than 10 mmHg, with a corresponding MB reduction of −1.3. Furthermore, 21.05% and 23.69% of patients achieved reductions of 5–10 mmHg in SBP and DBP, accompanied by MB decreases of −1.7 and −2.3, respectively
